AI platform for data analytics, drug discovery unveiled

Uppaluri K&H Personalised Medicine Clinic Pvt Ltd., unveiled GeneConnectRx, an innovative AI platform from GenepoweRx, the diagnostic wing of the group. This revolutionary initiative in personalised medicine marks a paradigm shift, empowering healthcare providers to customise treatments based on individual genetic makeup. Padma Bhushan Dr D Nageshwar Reddy, Chairman and Chief of Gastroenterology at AIG Hospitals, launched the initiative and contributed his invaluable expertise. Penmetsa Venkata Subba Raju, Vice-Chairman of AIG Hospitals, Prof. Ch Mohan Rao, CSIR – Distinguished Scientist and Former Director, CCMB, Dr Kalyan Uppaluri and Hima J Challa, founders of K&H clinics and pioneers behind GeneConnectRx, were present.
GeneConnectRx represents the collaborative efforts of a multidisciplinary team comprising computational scientists, molecular biologists, bioinformaticians and chemoinformaticians. Over two years, this team identified drug targets for complex medical conditions.
Dr Nageshwar Reddy commented, “Personalised medicine must become standard practice in every hospital. Focused research in this space is crucial to provide accurate, effective and affordable personalised medicine products to all individuals.”
Dr Vinayender Tulla added, “GeneConnectRx holds the potential to revolutionise drug discovery by decoding genetic information, enabling targeted and personalised therapies for more effective treatments.”
“Our collaboration with AIG Hospitals has resulted in groundbreaking initiatives like AIG’s pharmacogenomics study. GeneConnectRx integrates internal data, global resources and cutting-edge models to forecast potential molecules for revolutionary drug discovery,” highlighted Dr Hima Challa.Ultimately, GeneConnectRx serves as the bridge connecting genetic data to diseases, identifying targets and paving the way for potential cures.